Is Besudil/Yilaike considered a hormonal drug?
Belumosudil mesylate tablets (Belumosudil) is not a hormone drug, but a small molecule targeted immunomodulator. Its mechanism of action is essentially different from that of glucocorticoids. Traditional treatments for chronic graft-versus-host disease (cGVHD) mostly rely on hormonal drugs, such as prednisone or methylprednisolone, which reduce the inflammatory response by broadly suppressing the immune system. Although hormone therapy can quickly control symptoms in the short term, long-term use can cause side effects such as osteoporosis, high blood sugar, and increased risk of infection. In contrast, the emergence of besudil marks a new stage in cGVHD treatment from "non-specific immunosuppression" to "precision immune regulation".

Besudil selectively inhibitsRho-related protein kinase 2 (ROCK2), thereby reducing the production of inflammatory factors, regulating T cell balance, especially promoting the functional recovery of regulatory T cells (Treg) and reducing autoimmune attacks. This mechanism can more accurately repair immune imbalances without affecting the body's normal immune defense. Therefore, it does not have the systemic side effects of hormonal drugs, nor will it cause typical hormonal dependence or withdrawal reactions.
Clinically, besudil is often used in patients with cGVHD who are ineffective or intolerant to hormone therapy, and has become an important second-line or third-line treatment option. It can be used as a single drug or in combination with low-dose hormones to help gradually reduce hormone dependence and improve long-term medication safety. From a pharmacological perspective, Besudil is a targeted immunomodulator rather than a hormonal drug. Its advantages include strong specificity, few side effects, and long-term maintenance of immune balance.
To sum up, besudil is not a hormonal drug, but an innovative targeted immunotherapy, providing a safer and longer-lasting treatment option for patients with chronic graft-versus-host disease. As the drug is promoted in China, its non-hormonal properties also make more doctors inclined to use it as an alternative or combined solution to help patients achieve long-term immune stability and improve their quality of life.
Reference: https://www.drugs.com/pro/rezurock.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)